Tvardi Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold TVRD, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
13
Funds holding
$1082742
Total value held
Selling
4 added/new · 7 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | American Financial Group Inc | $424952 | 223659 | — | Held |
| 2 | Ubs Group Ag | $211153 | 111133 | +111133 | NEW BUY |
| 3 | Blackrock, Inc. | $181408 | 95478 | -292597 | -75.40% |
| 4 | Morgan Stanley | $147905 | 77845 | +4951 | +6.79% |
| 5 | State Street Corp | $64410 | 33900 | -63331 | -65.13% |
| 6 | Northern Trust Corp | $41489 | 21836 | -27245 | -55.51% |
| 7 | Pnc Financial Services Group, Inc. | $6685 | 3518 | +2999 | +577.84% |
| 8 | Wells Fargo & Company/Mn | $2422 | 1275 | -991 | -43.73% |
| 9 | Barclays Plc | $1074 | 565 | -381 | -40.27% |
| 10 | Royal Bank Of Canada | $1000 | 466 | +381 | +448.24% |
| 11 | Jpmorgan Chase & Co | $240 | 126 | -2439 | -95.09% |
| 12 | Fifth Third Bancorp | $2 | 1 | — | Held |
| 13 | Citigroup Inc | $2 | 1 | -122 | -99.19% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.